knowledge -WSS

knowledge

author：entertainment 2025-09-30 00:35:35 - browse：626

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello, friends! I’m in San Francisco for the STAT Breakthrough Summit. Later today, I’ll be “fireside chatting” with Cytokinetics CEO Robert Blum. It’s not too late to join us virtually. Check out details here.

It’s a travel-shortened week for me, so in this newsletter, I decided to dive deep into PDS Biotech and its experimental drug for head and neck cancer. PDS is what I’d call a biotech cult stock.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Weight loss drugs should be covered by insurers, AMA says

focus

WSS

Publishing genetic code of viruses could cause disaster

A letter from the executive editor: STAT UnitedHealth investigation

Congress must protect the remaining independent doctors

Long Covid research funding gets a major boost from NIH

Cancer diagnosis changes perspective doctor, former hospital CEO

Cancer diagnosis changes perspective doctor, former hospital CEO

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Supreme Court strikes down use of affirmative action

UnitedHealth sued over use of algorithm in Medicare Advantage plans

How to save PrEP access — and even expand it

Why don't Americans have at

Jerome Adams on the need for new antivirals for Covid

STAT Boddities: What happens to the brain when we get scared?

In Memoriam: Notable people who died in 2023

Healthy food access boosts outcomes in two studies

Guidelines to prevent youth baseball injuries need more muscle

UnitedHealth sued over use of algorithm in Medicare Advantage plans

explore

What health policies could hitch a ride on a spending bill?

Latigo launches with $135 million for Vertex

AMAs digital advisors table RPM coding reform proposal, again

FDA reorg will put new emphasis on investigations, sources say

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Having children helps parents live longer, especially after age 80

explore

focus

hotspot

focus